Creative Planning Plus Therapeutics, Inc. Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.27 - $0.48 $0 - $0	1 Added 0.0%	33,540 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.46 - $1.02 $5,750 - $12,750	12,500 Added 59.41%	33,539 $18,000
Q4 2021 Feb 11, 2022	BUY	$1.03 - $1.94 $2,575 - $4,850	2,500 Added 13.49%	21,039 $22,000
Q2 2021 Aug 04, 2021	BUY	$2.0 - $2.89 $4,366 - $6,308	2,183 Added 13.35%	18,539 $47,000
Q1 2021 Apr 30, 2021	BUY	$2.1 - $3.75 $5,250 - $9,375	2,500 Added 18.04%	16,356 $39,000

Q4 2020 Jan 29, 2021	BUY	$2.0 - $2.76 $27,712 - $38,242	13,856 New	13,856 $28,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $51.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.